Reference Distributions for Alpha2-Macroglobulin: A Practical, Simple and Clinically Relevant Approach in a Large Cohort

Journal of Clinical Laboratory Analysis

Volumn 18, Issue 2, 2004, Pages 139-147

  Ritchie, Robert F ^a,b   Palomaki, Glenn E ^a   Neveux, Louis M ^a   Navolotskaia, Olga ^a   Ledue, Thomas B ^a   Craig, Wendy Y ^a  

^a FOUNDATION FOR BLOOD RESEARCH   (United States)

^b NONE   (United States)

Author keywords

Acute phase response; Alpha2 macroglobulin; Caucasian; CRM 470 RPPHS; Reference range

Indexed keywords

ALPHA 2 MACROGLOBULIN; C REACTIVE PROTEIN;

ACUTE PHASE RESPONSE; ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CAUCASIAN; CHILD; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; INFLAMMATION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; NEPHROTIC SYNDROME; RISK FACTOR; SEX DIFFERENCE; BLOOD ANALYSIS; COHORT ANALYSIS; INFANT; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; REFERENCE VALUE; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALPHA-MACROGLOBULINS; BLOOD CHEMICAL ANALYSIS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NEW ENGLAND; REFERENCE VALUES;

EID: 1842638696     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcla.20012     Document Type: Article

References (66)

1. Jinbo T, Sakamoto T, Yamamoto S. Serum alpha2-macroglobulin and cytokine measurements in and acute inflammatory model in rats. Lab Anim 2002:36:153-157.
2. Souza CT, Moura MB, Magalhaes A, et al. Inhibition of mutalysin II, a metaloproteinase from bushmaster snake venom by human alpha2-macroglobulin and rabbit immunoglobulin. Comp Biochem Physiol B Biochem Mol Biol 2001;130:155-168.
3. Wallmo L, Gyzander E, Karlsson K, Lindstedt G, Radberg T, Teger-Nilsson AC. Alpha 2-antiplasmin and alpha 2-macroglobulin-the main inhibitors of fibrinolysis-during the menstrual cycle, pregnancy, delivery and treatment with oral contraceptives. Acta Obstet Gynecol Scand 1982;61:415-422.
4. Ramcharan S, Sponzilli EE, Wingerd JC. Serum protein fractions. Effects of oral contraceptives and pregnancy. Obstet Gynecol 1976;48:211-215.
5. de Sain-van der Velden MG, Rabelink TJ, Reijngoud DJ, et al. Plasma alpha 2 macroglobulin is increased in nephrotic patients as a result of increased synthesis alone. Kidney Int 1998;54:530-535.
6. Aviles-Santa L, Alpern R, Raskin P. Reversible renal failure and nephrotic syndrome in a type 1 diabetic patient. J Diabetes Complications 2002;16:249-254.
7. 2-macroglobulin in diabetes. Lancet 1976;2:1020-1021.
8. Lynn KL, Frendin TJ, Waiker RJ, Bailey RR, Swainson CP. Renal disease in diabetics-which patients have diabetic nephropathy and what is their outcome? Aust N Z J Med 1988;18:764-767.
9. James K, Merriman J, Gray RS, Duncan LJ, Herd R. Serum alpha 2-macroglobulin in diabetes. J Clin Pathol 1980;33:163-166.
10. Wilmer WA, Hebert LA, Lewis EJ, et al. Remission of nephrotic syndrome in type 1 diabetes: long-term follow-up of patients in the Captopril Study. Am J Kidney Dis 1999;34:308-314.
11. Davis A. Renal disease, overview. In: Ritchie RF, Navolotskaia O, editors. Serum proteins in clinical medicine, volume II, clinical section. Scarborough. Maine: Foundation for Blood Research: 1999. p 116.00.1-4.
12. Goldman M, Herbert D, Geary DF. Management of steroid-sensitive nephrotic syndrome in children with type 1 diabetes. Pediatr Nephrol 2002;17:351-354.
13. Dornan TL, Jenkins S, Cotton RE, Tattersall RB, Burden RP. The nephrotic syndrome at presentation of insulin-dependent diabetes mellitus: cause or coincidence. Diabet Med 1988;5:387-390.
14. Ceriello A, Quatraro A, Dello Russo P, Marchi E, Barbanti M, Giugliano D. Hyperglycemia-conditioned increase in alpha-2-macroglobulin in healthy normal subjects: a phenomenon correlated with deficient antithrombin III activity. Acta Haematol 1989;82:61-63.
15. Kramer L, Horl WH. Hepatorenal syndrome. Semin Nephrol 2002;22:290-301.
16. Briglia AE, Anania FA. Hepatorenal syndrome. Definition. pathophysiology, and intervention. Crit Care Clin 2002;18: 345-373.
17. Naveau S, Poynard T, Benattar C, Bedossa P, Chaput JC. Alpha-2-macroglobulin and hepatic fibrosis. Diagnostic interest. Dig Dis Sci 1994;39:2426-2432.
18. Laurell C-B, Jeppsson J-O. Protease inhibitors in plasma. In: Putnam F, editor. The plasma proteins, structure, function and genetic control. Volume 1, New York: Academic Press: 1975. p 229-264.
19. Mahour GH, Song MK, Adham NF, Rinderknecht H. Alpha2-macroglobulin deficiency in a patient with Ehlers-Danlos syndrome. Pediatrics 1978;61:894-897.
20. Bergqvist D, Nilsson IM. Hereditary alpha 2-macroglobulin deficiency. Scand J Haematol 1979;23:433-436.
21. Raubenstine DA, Ballantine TVN, Greecher CP, Webb SL. Neonatal serum protein levels as indicators of nutritional status: normal values and correlation with anthropometric data. J Pediatr Gastroenterol Nutr 1990;10:53-61.
22. Matthijs G, Devriendt K, Cassiman JJ, Van den Berghe H, Marynen P. Structure of the human alpha-2 macroglobulin gene and its promotor. Biochem Biophys Res Commun 1992;284: 596-603.
23. Poller W, Barth J, Voss B. Detection of an alteration of the alpha 2-macroglobulin gene in a patient with chronic lung disease and alpha 2-macroglobulin deficiency. Hum Genet 1989;183: 93-96.
24. Poller W, Faber JP, Klobeck G, Olek K. Cloning of the human alpha 2-macroglobulin gene and detection of mutations in two functional domains: the bail region and the thiolester site. Hum Genet 1992;88:313-319.
25. Du Y, Ni B, Glinn M, et al. Alpha2-macroglobulin as a beta-amyloid peptide-binding plasma protein. J Neurochem 1997;69:299-305.
26. 2-macroglobulin with Alzheimer's disease in a Finnish elderly population. Ann Neurol 1996;46:382-390.
27. Wetterling T, Tegtmeyer KF. Serum alpha 1-antitrypsin and alpha 2-macroglobulin in Alzheimer's and Binswanger's disease. Clin Invest 1994;72:196-199.
28. Seacchi R, Ruggeri M, Gambina G, Martini MC, Corbo RM. Alpha2-macroglobulin deletion polymorphism and plasma levels in late onset Alzheimer's disease. Clin Chem Lab Med 2002;40:333-336.
29. Borth W. Alpha 2-macroglobulin, a multifunctional binding protein with targeting characteristics. FASAB J 1992;6: 3345-3353.
30. Gunnarson M, Jensen PE. Binding of soluble myelin basic protein to various conformational forms of alpha2-macroglobulin. Arch Biochem Biophys 1998;359:192-198.
31. Whicher JT, Ritchie RF, Johnson AM, et al. New international reference preparation for proteins in human serum (RPPHS). Clin Chem 1994;40:934-938.
32. Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TB, Craig WY. Reference distributions for immunoglobulins A, G and M: a practical, simple and clinically relevant approach in a large cohort. J Clin Lab Anal 1998;12:363-370.
33. Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TB, Craig WY. Reference distributions for the negative acute phase proteins, albumin, transferrin and transthyretin: a practical, simple and clinically relevant approach in a large cohort. J Lab Clin Anal 1999;13:273-279.
34. 1-antitrypsin, and haptoglobin: a practical, simple, and clinically relevant approach to a large cohort. J Clin Lab Anal 2000:14:284-292.
35. Ritchie RF, Palomaki GE, Navolotskaia O, Neveux LM, Ledue TB, Craig WY. Reference distributions for serum iron and transferrin saturation: a practical, simple, and clinically relevant approach in a large cohort. J Clin Lab Anal 2002; 16:237-245.
36. Ritchie RF, Palomaki GE, Navolotskaia O, Neveux LM, Leduc TB, Craig WY. Reference distributions for the complement components C3 and C4: a comparison of a large cohort to the world's literature. J Lab Clin Anal 18:148-152.
37. 2-macroglobulin: a comparison of a large cohort to the world's literature. J Lab Clin Anal (in press).
38. Healy MJR. Outliers in chemical chemistry quality-control schemes. Clin Chem 1979;25:675-677.
39. Shiota G, Umeki K, Okano J, Kawasaki H. Hepatocyte growth factor and acute phase proteins with chronic liver diseases. J Med 1995;26:295-304.
40. Winslet MC, Sherwell J, Radley S, Keighley MRB. The acute phase protein response in Crohn's colitis. Biochem Soc Trans 1991;19:222S.
41. Agostoni A, Marasini B, Stabilini R, Del Ninno E, Pontello M. Multivariate analysis of serum protein assays in chronic hepatitis and postnecrotic cirrhosis. Clin Chem 1974;20:428-429.
42. Pongpaew P, Schelp FP. Albumin, prealbumin, transferrin and serum proteinase inhibitors in asymptomatic and hospitalized Thai alcohol drinkers. J Stud Alcohol 1983;44:381-383.
43. Finotti P, Piccoli A, Carraro P. Alteration of plasma proteinase-antiproteinase system in type 1 diabetic patients. Influence of sex and relationships with metabolic control. Diabetes Res Clin Pract 1992;18:35-42.
44. Vaziri ND, Gonzales EC, Shayestehfar B, Barton CH. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome. J Lab Clin Med 1994;124: 118-124.
45. Ledue TB, Johnson MJ, Cohen LA, Ritchie RF. Evaluation of proficiency survey results for serum immunoglobulins following the introduction of a new international reference material for human serum proteins. Clin Chem 1998;44:878-879.
46. Banks RE, Evans SW, Alexander D, Van Leuven F, Whicher JT, McMahon MJ. Related articles, alpha 2 macroglobulin state in acute pancreatitis. Raised values of alpha 2 macroglobulin-protease complexes in severe and mild attacks. Gut 1991;32: 430-434.
47. Aasen AO, Erichsen NS, Gallimore MJ, Amundsen E. Studies on components of the plasma kallikrein-kinin system in plasma samples from normal individuals and patients with septic shock. Adv Shock Res 1980;4:1-10.
48. McMahon MJ, Bowen M, Mayer AD, Cooper EH. Relation of alpha 2-macroglobulin and other antiproteases to the clinical features of acute pancreatitis. Am J Surg 1984;147:164-170.
49. Doherty NS, Littman BH, Reilly K, Swindell AC, Buss JM, Anderson M. Analysis of changes in acute-phase plasma proteins in an acute inflammatory response and in rheumatoid arthritis using two-dimensional gel electrophoresis. Electrophoresis 1998;19:355-363.
50. Van Gool J, van Vugt H, de Bont E. Alpha 2-macroglobulin and fibrinogen modulate inflammatory edema in man. Inflammation 1990;14:275-283.
51. Cannon JG, Angel JB, Ball RW, Abad LW, Fagioli L, Kamaroff AL. Acute phase responses and cytokine secretion in chronic fatigue syndrome. J Clin Immunol 1999;19:414-421.
52. Burnett D, Stockley RA. Serum and sputum alpha 2 macroglobulin in patients with chronic obstructive airway disease. Thorax 1981;36:512-516.
53. Condacci I, Cimasoni G, Ahmad-Zadeh C. Alpha 2-macroglobulin in sulci from healthy and inflammed human gingiva. Infect Immunol 1982;36:66-71.
54. Tsouris JA, Mehta PD, Patti PJ, et al. Alpha2 macroglobulin elevation without an acute phase response in depressed adults with down's syndrome: implications. J Intellect Disabil Res 2000;44:644-653.
55. Anneren G, Gebre-Medhin M. Trace elements and transport proteins in serum of children with Down syndrome and of healthy siblings living in the same environment. Hum Nutr Clin Nutr 1987;41:291-299.
56. Makis AC, Hatzimichael EC, Mavridis A, Bourantas KL. Alpha-2-macroglobulin and interleukin-6 levels in steady-state sickle cell disease patients. Acta Haematol 2001;104:164-168.
57. Roberts RC, Hall PK, Nikolai TF, McKenzie AK. Reduced trypsin binding capacity of alpha 2-macroglobulin in diabetics. Clin Chem Acta 1986;154:85-101.
58. Gray RS, James K, Merriman J, et al. Alpha 2-macroglobulin and proliferative retinopathy in type 1 diabetes. Horm Metab Res 1982;4:389-392.
59. Volpi A, Piaserico PL. Alpha2-macroglobulin in diabetic disease and in its microangiopathic complications. Minerva Med 1983;74:2287-2289.
60. Turecky L, Kupcova V, Szantova M. Alpha 2-macroglobulin in the blood of patients with diabetes mellitus. Bratisl Lek Listy 1999;100:25-27.
61. Ahmad J, Singh M, Saleemuddin M. A study of plasma alpha-2-macroglobulin levels in type 2 diabetic subjects with microalbuminuria. J Assoc Physicians India. 2001;49:1062-1065.
62. Ohtani H. Immunological background of plasma protein abnormalities-the relation between inflammation and malignant neoplasm. Rincho Byori 1999;47:909-916.
63. Kanoh Y, Ohtani N, Mashiko T, et al. Levels of alpha 2 macroglobulin can predict bone metastases in prostate cancer. Anticancer 2001;21:551-556.
64. Ohtani H, Saito M, Koshiba K. Alpha-2-macroglobulin deficiency in patients with advanced prostate cancer. Oncology 1985;42: 341-344.
65. National Committee for Clinical Laboratory Standards. How to define and determine reference intervals in the clinical laboratory: approved guideline. NCCLS document C28-A. Villanova, PA: NCCLS: 1995.
66. Gräsbeck R, Siest G, Wilding P, Williams GZ, Whitehead TP. Provisional recommendation on the theory of reference values. Part 1. The concept of reference values. Clin Chim Acta 1978;87:461F-465F.